Protuoso Biosciences develops next-generation multifunctional biologics designed to address complex disease biology.
Protuoso Biosciences has raised $9.5M in total funding. The most recent round was Seed. The last funding was announced in May 2026.
Protuoso Biosciences's investors include Darwin Ventures, Seeds Capital, Taya Venture Capital, NSG Ventures.
Protuoso Biosciences is headquartered in San Carlos, United States.
Protuoso Biosciences develops next-generation multifunctional biologics designed to address complex disease biology.
Protuoso Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Protuoso Biosciences — Funding & Investors." VCBacked, May 27, 2026, https://www.vcbacked.co/company/protuoso-biosciences. Accessed September 30, 2026.
VCBacked. (2026). Protuoso Biosciences — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/protuoso-biosciences
{{cite web |title=Protuoso Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/protuoso-biosciences |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated